Explore Stanford technologies available for licensing:

Stanford researchers within the Cui Lab have discovered a promising practical application for grid-scale energy storage by solving poor electronic conductivity in Mn based aqueous batteries, resulting in cycling with an ultrahigh areal loading of 20 mAh cm-2 for over 200 cy

Non-alcoholic steatohepatitis (NASH) is the most common liver disease, leading to cirrhosis and hepatocellular carcinoma (HCC). HCC is one of the most common cancers and has a dismal prognosis as currently available medical treatment only improves survival by a few months.

Stanford researchers at the Woo Lab have designed and manufactured a flexible, compact laparoscopic device for knot tying during cardiac, thoracic, and ENT operations.

Stanford scientists have discovered that a subset of human cathepsins can degrade cancer-associated mucins.

Stanford researchers have created a system that enables efficient fabrication of complex three-dimensional (3D) nanostructures via triplet-triplet-annihilation upconversion (TTA-UC).

Stanford scientists have developed a novel approach to help patients with short bowel syndrome by using intestinal lengthening. The solution involves injecting a degradable hydrogel into the intestinal wall to narrow the lumen and enable the confinement of a coiled spring.

Researchers in the Murmann Mixed Signal Group have developed a pipelined chip architecture with inverted residual and linear bottlenecks-based networks for energy efficient Machine Learning inference on edge devices.

Stanford scientists have created software, referred to as Symbolica, for automating model development for multiscale systems that can accelerate the generation of multi-physical models by 10^5 times what can be completed by hand.

Technology Reference: Chan Zuckerberg CZB-190S; Stanford S20-449

Summary
Researchers at Stanford have developed a method enabling quantification of intracellular protein levels using oligonucleotide-barcoded antibodies.

Researchers at Stanford University have developed a method which integrates cell barcoding and high-throughput sequencing to quantify tumor growth in genetically engineered mouse models of human cancer (called 'Tuba-seq” for Tumor barcoding coupled with seq

Researchers at Stanford have identified GPR84 as a new highly specific imaging biomarker of neuroinflammation and innate immune activation.

Stanford researchers at the Woo Lab have developed an innovative supra-hemostasis aortic graft, an advanced version of conventional aortic grafts. Current aortic grafts do not have reinforced suture area which can cause bleeding around the anastomosis line.

Stanford researchers at the Woo Lab have designed an innovative prosthetic valve to address challenges in mitral valve replacement for patients with severe mitral annular calcification (MAC).

Researchers at Stanford have proposed that coating surgical sutures with mechanotransduction inhibitors may reduce scarring of the tissue.

Stanford researchers have developed a cost effective replacement for bipolar membrane (BPM) electrodialysis, called bipolar electrode (BPE) that more efficiently splits water into separate streams of protons and hydroxide ions.